about
The tau tubulin kinases TTBK1/2 promote accumulation of pathological TDP-43Dopamine D2 receptor antagonism suppresses tau aggregation and neurotoxicityCDC7 inhibition blocks pathological TDP-43 phosphorylation and neurodegeneration.Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis.Loss of RAD-23 Protects Against Models of Motor Neuron Disease by Enhancing Mutant Protein ClearanceTDP-43/FUS in motor neuron disease: Complexity and challenges.The phosphatase calcineurin regulates pathological TDP-43 phosphorylation.Sertraline, Paroxetine, and Chlorpromazine Are Rapidly Acting Anthelmintic Drugs Capable of Clinical Repurposing.Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration.Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defectsConstitutive XBP-1s-mediated activation of the endoplasmic reticulum unfolded protein response protects against pathological tauPhenotypic Suppression of ALS/FTD-Associated Neurodegeneration Highlights Mechanisms of DysfunctionTau tubulin kinases in proteinopathyGenome wide analysis reveals heparan sulfate epimerase modulates TDP-43 proteinopathyActivity of the poly(A) binding protein MSUT2 determines susceptibility to pathological tau in the mammalian brainResistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort
P50
Q28542476-5DBAC30A-951D-41F9-9704-AC5AEA1EDFB1Q30535414-3722334B-48F2-4BAD-8755-3868732EB102Q30544943-16740EB8-A450-4A1C-97EE-36B8488F8E67Q30574827-B629C73B-8793-433E-BB55-69CE2CB4D540Q36383297-0E5611AC-0D3C-4ED0-A1D2-85957295A567Q38969736-843D70E3-4C2A-4C21-AAFD-A5EDE1F9A903Q41628256-05476B58-A91A-4431-B739-D911B36C3D1BQ47653287-D33BEBE2-26E3-46AB-9C69-90282953529AQ48096252-CF026514-17C1-4865-8C07-F11326F2AF34Q64387891-C29EC88D-79E7-406A-857E-91436DFF124AQ90389873-0DA3C089-1FC4-4A1D-8E5B-77D5A3AA3B80Q90753165-A18C3569-3174-4A05-8715-1341260D6582Q91606146-24EF4C08-7EFF-4222-87DF-BDFECA8528E3Q91958990-A381695B-9B86-4428-88BC-D9A356A1E9B6Q92094315-B464CA04-BBCF-4F8D-800E-FD6B465A9104Q92591355-DA5257B9-74D3-4DDE-9FAC-509C14C8843D
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Nicole F Liachko
@en
Nicole F Liachko
@nl
type
label
Nicole F Liachko
@en
Nicole F Liachko
@nl
prefLabel
Nicole F Liachko
@en
Nicole F Liachko
@nl
P31
P496
0000-0003-1250-3871